April 11th 2025
The new approval is the first nonopioid option for moderate to severe acute pain in adults.
April 9th 2025
Pharmacists are well positioned to screen for diversion, monitor for opioid use disorder, and educate patients on opioid-related risks.
April 8th 2025
There were no statistically significant differences between cognitive behavioral therapy and mindfulness-based therapy in reducing the dosage for chronic lower back pain.
April 3rd 2025
Traditional approaches have typically relied on oral medications, which can expose the entire body to potentially harmful adverse effects.
March 21st 2025
According to poison control data, many children aged 0 to 17 experience toxicity from over-the-counter analgesics like ibuprofen and acetaminophen.
Complementary, Alternative OTC Drugs Pivotal in the Treatment of Acute Pain
As pharmacists move away from opioids in pain management, researchers present the use of supplemental OTC products to assist patients’ acute pain.
Nonopioid Therapy For Acute Pain Shows Positive Results in Phase 3 Trial
Cebranopadol met its primary endpoint of reduction in pain intensity as measured by the Pain Numeric Rating Scale (NRS) area under the curve from 2 through 48 hours.
Q&A: The Role of Emerging Technologies in the Future of Pain Management
In a third installment of our interview series with Chris Robinson, MD, PhD, we looked at the future of pain management and emerging technologies being used for treatment.
Polyphenols Show Potential in Treating Fibromyalgia Pain
In a search for new treatment and prevention strategies for pain in patients with fibromyalgia, researchers explored bioavailable nutraceuticals and phytochemicals like polyphenols.
Q&A: Why Educating Patients on Emerging Pain Technology is Key
Chris Robinson, MD, PhD, joined Drug Topics to discuss the importance of education in newly explored technologies for the treatment of pain.
Topical Medications as First-Line Treatment Options for Orofacial Pain
Researchers investigated the pharmacological management of chronic orofacial pain and provided guidance on its proper treatment.
Q&A: Innovative Technologies Revolutionizing Pain Medicine
Physician with expertise in pain research discussed emerging technologies in the future of pain medicine and how they must be adapted to improve patient outcomes.
Cryotherapy Spray Reduced Pain, Improved Joint Mobility
Patients with musculoskeletal pain were treated with cryotherapy spray to assess its use in providing immediate and sustained pain relief.
Esketamine Safe, Effective for Treating Postoperative Pain
Researchers investigate the effects of subanesthetic doses of esketamine for the treatment of pain and cognition in patients undergoing surgery.
Q&A: How Will Suzetrigine Impact the Pain Management Landscape?
A discussion on the new nonopioid selective NaV1.8 pain signal inhibitor with Madison Irwin, PharmD, BCPS.
AI Haptic Feedback Technology Reduced Nocturnal Scratching in Atopic Dermatitis
For patients with atopic dermatitis reporting moderate-to-severe scratching, researchers explored the efficacy of an AI-enabled wearable sensor with closed-loop haptic feedback.
Healthy Cardiovascular System Associated with Increased Migraine Incidence
Cardiovascular health is known to be associated with the probability of having active or developing migraine in the future.
Non-Oral Therapies Have Made Significant Progress in Treating Shingles Pain
Researchers conducted a review of clinical studies to better understand non-oral drugs for the treatment of pain related to herpes zoster.
Adults with Chronic Pain Support Cannabis Use More Than Physicians
Researchers asked adults with chronic pain and physicians their opinions on cannabis regulations.
Reducing Opioid Prescriptions for Lower Back Pain Increases NSAID, Paracetamol Use
Reducing the number of opioid prescriptions for patients with lower back pain did not result in an increased use of other, risky pain medications.
Lifestyle Management Showed Minimal Improvements for Chronic Low Back Pain
Assessing the management of chronic low back pain, researchers compared outcomes of healthy lifestyle care with current guideline-recommended care.
Cannabis Use Does Not Predict Relief in Patients With Chronic Pain
A recent study found that edible or smoked cannabis use predicted little variability in pain relief.
FDA Approves Actemra Biosimilar Tocilizumab-Anoh
Tocilizumab-anoh is the biosimilar formulation for ACTEMRA, a medication used to treat rheumatoid arthritis, COVID-19, and other diseases.
FDA Approves Suzetrigine For Treatment of Acute Pain
The decision makes the selective NaV1.8 pain signal inhibitor the first new class of medicine to treat acute pain in over 20 years.
Gestational Age Associated with Pain Among Very Preterm Infants
Researchers analyzed liveborn infant data from January 2020 to June 2024 to determine prevalence, cause, and treatment strategies for pain among preterm infants.
Cebranopadol Shows Lower Abuse Potential Compared to Existing Pain Therapies
A supratherapeutic dose of 1000 ug cebranopadol was significantly less likeable compared to 40 mg oxycodone when crushed and taken intranasally.
Secukinumab Demonstrates Real-World Efficacy in Treating Psoriatic Arthritis
Researchers conducted a literature review of patients’ clinical experiences with using secukinumab to treat psoriatic arthritis.
Nonopioid Therapy Shown to Significantly Reduce Pain Intensity in Phase 3 Trial
Cebranopadol is a first-in-class investigational therapy that targets the nociceptin/orphanin FQ receptor and the µ-opioid receptor.
Nonopioid Combination More Effective Than Opioids at Managing Postsurgical Pain
A combination of ibuprofen and acetaminophen was found to be superior to hydrocodone and acetaminophen in managing pain after impacted mandibular third-molar extraction surgery.
Non-Opioid Analgesic Shown to Reduce Post-Surgical Pain in Phase 2 Trial
XG005 from Xgene Pharmaceutical is a novel, non-opioid chemical entity that targets anti-nociceptive and anti-neuropathic pain pathways.
Nonopioid Pain Management: Most Read Stories From 2024
Check out this list of our top 5 most read nonopioid pain management stories from the year 2024.
Neck Pain Management Crucial for Patients with Medication-Overuse Headache
A study found that patients with medication-overuse headache and neck pain experience earlier onset of primary headache and decreased quality of life.
Navigating Cannabis Use in Health Care Settings | ASHP Midyear
Navigating Cannabis use requires more than just an understanding of the endocannabinoid system.
Post-Surgical Pain Treatment Gains FDA Breakthrough Therapy Designation
ATX101 from Allay Therapeutics is designed for use following total knee arthroplasty in adults and has shown positive results in multiple studies.
Cannabis Could Help Reduce Opioid Use in Patients with Chronic Pain
Most patients with reduced opioid prescriptions during cannabis use had chronic musculoskeletal pain.